Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
A confirmed history of NO use, along with the exclusion of other causes, supports the diagnosis
Patients and healthcare professionals are encouraged to report suspected adverse reactions via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk)
Regular monitoring of HbA1c and working with healthcare professionals to adjust treatment as needed can help prevent long-term complications
Before starting the medication, individuals should discuss their medical history, including any liver conditions or risk factors, with their healthcare provider
Read the full study: Retatrutide, a GIP, GLP-1 and Glucagon Receptor Agonist, for People with Type 2 Diabetes (Lancet 2023)
US$ 28.85
US$ 21.15
US$ 23.26
US$ 21.03
US$ 20.52
US$ 24.80
US$ 27.35
US$ 22.05
